Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy

Xiang-Hong Peng1,4, Ximei Qian2,4, Hui Mao3,4, Andrew Y Wang5, Zhuo (Georgia) Chen1,4, Shuming Nie2,4, Dong M Shin1,4*1Department of Medical Oncology/Hematology; 2Department of Biomedical Engineering; 3Department of Radiology; 4Winship Cancer Institute, Emory University School of Medicine, Atlanta,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiang-Hong Peng, Ximei Qian, Hui Mao, Andrew Y Wang, Zhuo (Georgia) Chen, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/517758b7535b4ab58af42b4f5c978c95
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:517758b7535b4ab58af42b4f5c978c95
record_format dspace
spelling oai:doaj.org-article:517758b7535b4ab58af42b4f5c978c952021-12-02T02:42:07ZTargeted magnetic iron oxide nanoparticles for tumor imaging and therapy1176-91141178-2013https://doaj.org/article/517758b7535b4ab58af42b4f5c978c952008-10-01T00:00:00Zhttp://www.dovepress.com/targeted-magnetic-iron-oxide-nanoparticles-for-tumor-imaging-and-thera-a2429https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Xiang-Hong Peng1,4, Ximei Qian2,4, Hui Mao3,4, Andrew Y Wang5, Zhuo (Georgia) Chen1,4, Shuming Nie2,4, Dong M Shin1,4*1Department of Medical Oncology/Hematology; 2Department of Biomedical Engineering; 3Department of Radiology; 4Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA; 5Ocean Nanotech, LLC, Fayetteville, AR, USAAbstract: Magnetic iron oxide (IO) nanoparticles with a long blood retention time, biodegradability and low toxicity have emerged as one of the primary nanomaterials for biomedical applications in vitro and in vivo. IO nanoparticles have a large surface area and can be engineered to provide a large number of functional groups for cross-linking to tumor-targeting ligands such as monoclonal antibodies, peptides, or small molecules for diagnostic imaging or delivery of therapeutic agents. IO nanoparticles possess unique paramagnetic properties, which generate significant susceptibility effects resulting in strong T2 and T*2 contrast, as well as T1 effects at very low concentrations for magnetic resonance imaging (MRI), which is widely used for clinical oncology imaging. We review recent advances in the development of targeted IO nanoparticles for tumor imaging and therapy.Keywords: iron oxide nanoparticles, tumor imaging, MRI, therapy Xiang-Hong PengXimei QianHui MaoAndrew Y WangZhuo (Georgia) Chenet alDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2008, Iss Issue 3, Pp 311-321 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Xiang-Hong Peng
Ximei Qian
Hui Mao
Andrew Y Wang
Zhuo (Georgia) Chen
et al
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
description Xiang-Hong Peng1,4, Ximei Qian2,4, Hui Mao3,4, Andrew Y Wang5, Zhuo (Georgia) Chen1,4, Shuming Nie2,4, Dong M Shin1,4*1Department of Medical Oncology/Hematology; 2Department of Biomedical Engineering; 3Department of Radiology; 4Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA; 5Ocean Nanotech, LLC, Fayetteville, AR, USAAbstract: Magnetic iron oxide (IO) nanoparticles with a long blood retention time, biodegradability and low toxicity have emerged as one of the primary nanomaterials for biomedical applications in vitro and in vivo. IO nanoparticles have a large surface area and can be engineered to provide a large number of functional groups for cross-linking to tumor-targeting ligands such as monoclonal antibodies, peptides, or small molecules for diagnostic imaging or delivery of therapeutic agents. IO nanoparticles possess unique paramagnetic properties, which generate significant susceptibility effects resulting in strong T2 and T*2 contrast, as well as T1 effects at very low concentrations for magnetic resonance imaging (MRI), which is widely used for clinical oncology imaging. We review recent advances in the development of targeted IO nanoparticles for tumor imaging and therapy.Keywords: iron oxide nanoparticles, tumor imaging, MRI, therapy
format article
author Xiang-Hong Peng
Ximei Qian
Hui Mao
Andrew Y Wang
Zhuo (Georgia) Chen
et al
author_facet Xiang-Hong Peng
Ximei Qian
Hui Mao
Andrew Y Wang
Zhuo (Georgia) Chen
et al
author_sort Xiang-Hong Peng
title Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
title_short Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
title_full Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
title_fullStr Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
title_full_unstemmed Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
title_sort targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/517758b7535b4ab58af42b4f5c978c95
work_keys_str_mv AT xianghongpeng targetedmagneticironoxidenanoparticlesfortumorimagingandtherapy
AT ximeiqian targetedmagneticironoxidenanoparticlesfortumorimagingandtherapy
AT huimao targetedmagneticironoxidenanoparticlesfortumorimagingandtherapy
AT andrewywang targetedmagneticironoxidenanoparticlesfortumorimagingandtherapy
AT zhuogeorgiachen targetedmagneticironoxidenanoparticlesfortumorimagingandtherapy
AT etal targetedmagneticironoxidenanoparticlesfortumorimagingandtherapy
_version_ 1718402218145611776